Hem › Astrocytom › Ohio
Kliniska studier för Astrocytom i Ohio
8 studier för Astrocytom söker deltagare vid platser i Ohio.
Städer i Ohio
Officiell studietext (engelska)
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Ohio State University Comprehensive Cancer Center, Columbus
- University of Cincinnati Cancer Center-West Chester, West Chester
RekryterarFas 3
Ålder 12 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT07215910Targeted Pediatric High-Grade Glioma Therapy
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekryterarObservationsstudie
12 Months – 39 Years · Alla kön · Uppdaterad 8 sep. 2026 · NCT05839379Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Ohio State University Comprehensive Cancer Center, Columbus
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06860594Study of Olutasidenib and Temozolomide in HGG
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekryterarFas 2
Ålder 12 till 39 · Alla kön · Uppdaterad 1 sep. 2026 · NCT06161974SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Cleveland Clinic, Cleveland
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT05303519Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekryterarTidig fas 1Friska volontärer välkomna
Ålder 1 till 21 · Alla kön · Uppdaterad 29 juni 2026 · NCT06333899Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RekryterarFas 2
12 Months – 39 Years · Alla kön · Uppdaterad 29 maj 2026 · NCT05843253Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
- The Cleveland Clinic, Cleveland
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 25 juni 2025 · NCT05879367Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.